SELENBP1 and colon adenocarcinoma: We also used TCGA Colon Adenocarcinoma (COAD) and Rectum Adenocarcinoma (READ) datasets (combined into the TCGA cohort), and a tissue microarray cohort [the tissue microarray (TMA) cohort] to validate the association between SELENBP1 expression and CRC patient prognoses.